Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Neonatal FeNO, risk factors, and respiratory morbidity in infants: A cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pulmonary diffusing capacity measured by NO/CO transfer in Tunisian boys

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Lung compartment analysis assessed from N2 multiple-breath washout in children with cystic fibrosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Exhaled Nitric Oxide in Premature and Mature Infants During the First Months of Life

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Challenges in conducting paediatric trials with off-patent drugs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Increased colon transit time and faecal load in irritable bowel syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Reproducibility of Glucose Fluctuations Induced by Moderate Intensity Cycling Exercise in Persons with Type 1 Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Respiratory symptoms in infancy are more common in premature infants. Nitric oxide (NO) is involved in prenatal and neonatal lung development. Measurement of exhaled NO is easy and well-tolerated by neonates. We investigated whether neonatal exhaled NO can be used to predict subsequent respiratory symptoms. Furthermore, we sought to determine prenatal and postnatal factors associated with increased respiratory symptom risk during the first year of life in premature and mature infants.

METHODS: Tidal fractional exhaled NO (FeNO) was measured in a birth cohort (n = 135) of premature and mature infants, up to six times during the first month of life. Primary outcomes were troublesome respiratory symptoms (TRS) and doctor-diagnosed asthmatic bronchitis (AB) at 1 year of age.

FINDINGS: The correlation between FeNO and TRS changed significantly in an age-dependent pattern in moderately premature infants (p = .02). Moderately premature infants with a low FeNO of 2 ppb on postnatal Day 3 had a 48% (95% confidence interval [CI]: 17%-80%) probability of TRS, compared with a probability of 12% (95% CI: 1%-64%) for otherwise similar infants with a FeNO of 11 ppb. Respiratory syncytial virus infection and parental smoking significantly increased the TRS risk in premature infants. Parental asthma and maternal antibiotic use during pregnancy significantly increased the TRS risk in mature infants.

INTERPRETATION: An age-specific association between neonatal FeNO and respiratory symptoms was seen in moderately premature infants. TRS risk was associated with postnatal factors in premature and prenatal factors in mature infants.

OriginalsprogEngelsk
TidsskriftPediatric Pulmonology
Vol/bind56
Udgave nummer10
Sider (fra-til)3174-3182
Antal sider9
ISSN8755-6863
DOI
StatusUdgivet - okt. 2021

ID: 66949667